ABBV vs MTD
By Alex · Tickerpine
AbbVie Inc. vs Mettler-Toledo International Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | ABBV | MTD |
|---|---|---|
| Price | $265.79 | $1,402.25 |
| Market cap | $469.68B | $28.10B |
| P/E ratio | 74.7 | 31.6 |
| ROE | — | — |
| Profit margin | 9.80% | 21.91% |
| Revenue growth | 10.20% | 4.50% |
| Dividend yield | 2.62% | — |
| Beta | 0.28 | 1.22 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
ABBV vs MTD in plain English
- ABBV is the bigger company — about 16.7× the market cap of MTD.
- MTD is cheaper on earnings (P/E 31.6 vs 74.7).
- ABBV is growing revenue faster (10% vs 4%).
- ABBV pays a dividend (2.62%) while the other effectively doesn't.
How would $1,000 have done in each?
ABBV return calculator
See what $1,000 in AbbVie Inc. would be worth today.
MTD return calculator
See what $1,000 in Mettler-Toledo International Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.